Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - HUMANIGEN, INC | kbio-20141231ex311ca12f3.htm |
| EX-32.1 - EX-32.1 - HUMANIGEN, INC | kbio-20141231ex3210bed6e.htm |
| EX-31.2 - EX-31.2 - HUMANIGEN, INC | kbio-20141231ex3123038e6.htm |
| EXCEL - IDEA: XBRL DOCUMENT - HUMANIGEN, INC | Financial_Report.xls |
| 10-K - 10-K - HUMANIGEN, INC | kbio-20141231x10k.htm |
| EX-32.2 - EX-32.2 - HUMANIGEN, INC | kbio-20141231ex322fb46d3.htm |
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S‑3 No. 333‑190972) of KaloBios Pharmaceuticals, Inc. and in the related Prospectuses and in the Registration Statement (Form S‑8 No. 333‑183725) pertaining to the 2001 Stock Plan and 2012 Equity Incentive Plan of KaloBios Pharmaceuticals, Inc. of our report dated March 16, 2015, with respect to the consolidated financial statements of KaloBios Pharmaceuticals, Inc. included in this Annual Report (Form 10‑K) for the year ended December 31, 2014.
/s/ Ernst & Young LLP
Redwood City, California
March 16, 2015